comprehensive -WSS

comprehensive

author：entertainment 2025-08-12 11:27:58 - browse：76

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： eGenesis tests gene

hotspot

WSS

Copay coupons to count toward deductibles, after Biden court move

Medicare Advantage today, explained in one chart

Alabama IVF ruling threatens families facing fatal genetic disease

Why doctors need education on FDA device approval process

AI generated plenty of interest at JPM but not a lot of trust

EU regulator recommends expanding Mounjaro approval to obesity

Wikipedia

comprehensive

Sign up for D.C. Diagnosis

focus

The high cost of giving birth even with insurance

Medicare inequities exacerbate Puerto Rico’s health disparities

Malaria cases in Florida and Texas: Here’s what you need to know

Alabama hospital puts IVF treatments on hold

State Dept. review finds Biden bears some blame for Afghanistan failures

Eli Lilly, Pfizer, and others want in on the online prescription market

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Independent physicians launch a new lobbying group

State Dept. review finds Biden bears some blame for Afghanistan failures

With competition flaring, obesity drug hits goal in liver disease study

entertainment

Community Health Systems hospitals under DOJ investigation

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Parkinson’s finding may lead to tests and, someday, treatments

Parkinson’s finding may lead to tests and, someday, treatments

New brain studies show LSD's effects on the brain in full color

NIH study of ME/CFS points to clear biological hallmarks

knowledge

hotspot

hotspot

hotspot